Replimune Group, Inc.
REPL
$5.67
$0.071.25%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 28.26% | 40.42% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.25% | 20.01% | |||
| Operating Income | -14.25% | -20.01% | |||
| Income Before Tax | -16.78% | -12.88% | |||
| Income Tax Expenses | -- | -118.61% | |||
| Earnings from Continuing Operations | -16.95% | -11.74% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -16.95% | -11.74% | |||
| EBIT | -14.25% | -20.01% | |||
| EBITDA | -19.08% | -15.63% | |||
| EPS Basic | -16.18% | -2.63% | |||
| Normalized Basic EPS | -16.03% | -3.66% | |||
| EPS Diluted | -16.18% | -2.63% | |||
| Normalized Diluted EPS | -16.03% | -3.66% | |||
| Average Basic Shares Outstanding | 0.66% | 8.88% | |||
| Average Diluted Shares Outstanding | 0.66% | 8.88% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||